Morgan Stanley raised the firm’s price target on Cinemark (CNK) to $30 from $28 and keeps an Equal Weight rating on the shares. Cinemark is “well positioned to benefit” from a box office recovery this year and next, but the firm cites risk to industry box office consensus and current valuation levels for its Equal Weight rating.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK: